These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16917959)

  • 1. The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160-mediated cytolytic effector function.
    Rey J; Giustiniani J; Mallet F; Schiavon V; Boumsell L; Bensussan A; Olive D; Costello RT
    Eur J Immunol; 2006 Sep; 36(9):2359-66. PubMed ID: 16917959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers.
    Pombo C; Wherry EJ; Gostick E; Price DA; Betts MR
    J Infect Dis; 2015 Nov; 212(9):1376-86. PubMed ID: 25883386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection.
    Chibueze CE; Yoshimitsu M; Arima N
    Biochem Biophys Res Commun; 2014 Oct; 453(3):379-84. PubMed ID: 25277889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
    Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
    Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.
    Nikolova M; Marie-Cardine A; Boumsell L; Bensussan A
    Int Immunol; 2002 May; 14(5):445-51. PubMed ID: 11978774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection.
    Ezinne CC; Yoshimitsu M; White Y; Arima N
    PLoS One; 2014; 9(2):e87631. PubMed ID: 24505299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.
    Kis-Toth K; Comte D; Karampetsou MP; Kyttaris VC; Kannan L; Terhorst C; Tsokos GC
    Arthritis Rheumatol; 2016 Jan; 68(1):164-73. PubMed ID: 26314831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells.
    Altvater B; Landmeier S; Pscherer S; Temme J; Juergens H; Pule M; Rossig C
    Cancer Immunol Immunother; 2009 Dec; 58(12):1991-2001. PubMed ID: 19360406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
    El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
    J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.
    Sako N; Schiavon V; Bounfour T; Dessirier V; Ortonne N; Olive D; Ram-Wolff C; Michel L; Sicard H; Marie-Cardine A; Bagot M; Bensussan A; Schmitt C
    Cytometry A; 2014 Oct; 85(10):869-82. PubMed ID: 25044837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier.
    Del Rio ML; Bravo Moral AM; Fernandez-Renedo C; Buhler L; Perez-Simon JA; Chaloin O; Alvarez Nogal R; Fernandez-Caso M; Rodriguez-Barbosa JI
    Transl Res; 2017 Mar; 181():83-95.e3. PubMed ID: 27702550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded antigen-experienced CD160
    Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation.
    Abecassis S; Giustiniani J; Meyer N; Schiavon V; Ortonne N; Campillo JA; Bagot M; Bensussan A
    J Invest Dermatol; 2007 May; 127(5):1161-6. PubMed ID: 17218942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Levels of CD244 Rather Than CD160 Associate With CD8
    Wang X; Wang D; Du J; Wei Y; Song R; Wang B; Qiu S; Li B; Zhang L; Zeng Y; Zhao H; Kong Y
    Front Immunol; 2022; 13():853522. PubMed ID: 35386693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD160: a unique activating NK cell receptor.
    Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N
    Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD160 expression on CD8
    Liu S; Zhang W; Liu K; Wang Y
    Cancer Immunol Immunother; 2020 May; 69(5):789-797. PubMed ID: 32055919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
    Speiser DE; Colonna M; Ayyoub M; Cella M; Pittet MJ; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini JC; Romero P
    J Immunol; 2001 Dec; 167(11):6165-70. PubMed ID: 11714776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity.
    Giustiniani J; Marie-Cardine A; Bensussan A
    J Immunol; 2007 Feb; 178(3):1293-300. PubMed ID: 17237375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine CD160+ CD8+ T lymphocytes.
    Tsujimura K; Obata Y; Matsudaira Y; Nishida K; Akatsuka Y; Ito Y; Demachi-Okamura A; Kuzushima K; Takahashi T
    Immunol Lett; 2006 Jul; 106(1):48-56. PubMed ID: 16764942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.